A Modeling Intervention in Heart Failure - Springer Link
Recommend Documents
... Failure: Past Challenges and Future Hopes. Jose H. Flores-Arredondo & Gerardo García-Rivas &. Guillermo Torre-Amione. Published online: 8 January 2011.
Apr 21, 2010 - an important role in the development of cardiac hypertrophy and heart failure and may ... but also the discovery of novel pharmacologic targets [8]. It is expected that ..... Estrogenic and antiandrogenic toxins that decrease male ...
Oct 6, 2010 - heart rate reduction with ivabradine in patients with heart failure [9]. Study Design. SHIFT is a randomized, double-blind, placebo-controlled,.
areas? Ben R. Craig Ð William E. Jackson III Ð. James B. Thomson. Received: 13 January 2006 / Accepted: 31 January 2007 / Published online: 26 May 2007.
Jun 9, 2010 - Liza S. M. Wong ⢠Pim van der Harst â¢. Rudolf A. de Boer ..... C, Wang TJ, Gardner JP, Cao X, Benjamin EJ, Levy D, Aviv A. (2008) Association ...
Aug 17, 2013 - 673â682, 1999. [24] T. Jaarsma, Lucas, and C. M. H. B, âNetherlands institute for continuing cardiovascular education (CVOI) self-assessment,â.
Sep 20, 2011 - Abstract Kinase inhibitors have emerged as an important new class of agents for the treatment of diverse tumors. Sunitinib malate is a ...
Dec 8, 2006 - Successful heart failure therapy in mitochondrial disorder with noncompaction cardiomyopathy. Josef Finsterer à Claudia Sto¨llberger Ã.
existing data concerning some of these problems, to pro- vide an aid for choosing the appropriate drugs in heart failure patients and minimizing the patient's risk.
Concomitant cardiac and renal dysfunction has been termed the cardiorenal syndrome (CRS). This clinical condition usually manifests as heart failure.
Apr 24, 2012 - self-report using the Revised HF Compliance Questionnaire. Results All ... ence, the rationale of choosing a cutpoint to define adher- ence in ...
Apr 24, 2012 - tom severity, depression, complexity and costs of the regi- men, perceived benefits and ..... Rodgers PT, Ruffin DM. Medication nonadherence: ...
May 20, 2011 - going. Intern Emerg Med. doi:10.1007/s11739-011-0600-0. 2. Tang WH, Francis GS, Morrow DA et al (2007) National. Academy of Clinical ...
Feb 17, 2010 - Abstract Galectin-3 is a member of the galectin family, which consists of animal lectins that bind β-galactosides. Recently, a role for galectin-3 in ...
May 29, 2007 - Jin H, Yang R, Keller GA, Ryan A, Ko A,. Finkle D, Swanson TA, Li W, Pennica ..... Vandegaer K, Gabrielson KL, O'Don- nell C P, Berkowitz DE, ...
Keywords: Heart failure, clinical dataset, classification, clustering, missing values, feature selection. 1 Introduction ... of medical care and treatment of patients with heart failure ...... 9th European Conference of Young Research and Scientific.
Oct 21, 2010 - Francisco Javier Carrasco Sánchez. Received: 16 ... Internal Medicine Department,. A´ rea Hospitalaria Juan Ramón Jiménez, Huelva, Spain.
Apr 9, 2018 - of the International Classification of Diseases (ICD)-10. Respective ICD-10 codes identifying heart failure within the German ICD-10 catalogue ...
Dec 14, 2013 - cystatin-C were weakly correlated to NYHA, oedema, jugular ... C. Knackstedt . ..... Evidence for brain natriuretic peptide as an âemergen-.
chronic heart failure (CHF) is exercise intolerance. ... (O2) uptake kinetics, describing the rate change of ... the heart to maintain sufficient cardiac output for.
Jan 27, 2016 - image acquisition during diastasis, body coil excite/receive. Lung image signal intensities from a single sagittal slice in the right lung were ...
A Modeling Intervention in Heart Failure - Springer Link
Aug 21, 2008 - effectiveness of a modeling intervention to increase Peak. VO2 (PVO2) and ... related to measured functional performance (6-min walk test and ..... intervention group (adjusted mean=22.46) compared to the control group ...
ann. behav. med. (2008) 36:64–69 DOI 10.1007/s12160-008-9050-y
ORIGINAL ARTICLE
A Modeling Intervention in Heart Failure Ralph Maddison, M.Sc. (Hons), Ph.D. & Harry Prapavessis, Ph.D. & Guy P. Armstrong, M.B.Ch.B. & Caleb Hill, B.H.Sc.
Published online: 21 August 2008 # The Society of Behavioral Medicine 2008
Abstract Background Peak oxygen uptake (VO2) testing is commonly used to assess chronic heart failure (CHF) patients’ exercise tolerance. The test requires maximal effort; however, many participants have low confidence (selfefficacy) to perform optimally. Purpose This randomized controlled trial examined the effectiveness of a modeling intervention to increase Peak VO2 (PVO2) and self-efficacy in people diagnosed with CHF. Methods Twenty participants with a diagnosis of CHF were randomized to either an intervention (modeling DVD) or a control group. Both groups completed a measure of selfefficacy prior to performing two PVO2 tests, each separated by 7 days. After completing the first test (T1) the
intervention group watched a 10-min coping model DVD. All participants returned 1 week later (T2) to complete identical study procedures. Results Analysis of covariance results showed that compared with the participants in the control group, those assigned to the modeling intervention had higher PVO2 at T2, F (1, 19)=4.38, p=0.05, ή2 =0.21 and self-efficacy, F (1, 19)=5.80, p
